Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-03-04
2008-03-25
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255050, C514S318000, C544S238000, C544S364000, C564S193000
Reexamination Certificate
active
07348327
ABSTRACT:
The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
REFERENCES:
patent: 3225037 (1965-12-01), Zenitz et al.
patent: 4001422 (1977-01-01), Danilewicz et al.
patent: 2004/0242636 (2004-12-01), Haffner et al.
patent: 2005/0176771 (2005-08-01), Hayakawa et al.
patent: 0 156 433 (1985-10-01), None
patent: 1308439 (2003-05-01), None
patent: 20020264450 (2002-09-01), None
patent: WO 98 19998 (1998-05-01), None
patent: WO 99 65895 (1999-12-01), None
patent: WO 01 96295 (2001-12-01), None
patent: WO 02 30890 (2002-04-01), None
patent: WO 02 38541 (2002-05-01), None
patent: WO 02 51836 (2002-07-01), None
patent: WO 03 000250 (2003-01-01), None
patent: WO 03 002531 (2003-01-01), None
patent: WO 03 002553 (2003-01-01), None
Database Crossfire Beilstein ′Online!; Beilstein Institut zur Forderung der Chemishen Wissenschaften, Frankfurt am Main, DE; Beilstein Registry No. 402384 & J. Med. Chem., vol. 17, 1974, pp. 739, 742; XP002242780.
Database Crossfire Beilstein ′Online!; Beilstein Institut zur Forderung der Chemishen Wissenschaften, Frankfurt am Main, DE; Beilstein Registry No. 8616397 & J. Med. Chem., vol. 43, No. 11, 2000, pp. 2087-2092; XP002242788.
Carling, R.W., et al; “1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dyhdroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D4 Receptor with Excellent Selectivity over Ion Channels”; J. Med. Chem. 1999, 42, pp. 2706-2715.
Moon, Sung-Hawn, et al; “An Efficient Conversion of Chiral α-Amino Acids to Enantiomerically Pure 3-Amino Cyclic Amines”; Synthetic Communications; 1998; 28(21); pp. 3919-3926.
Demange, Luc, et al; “Practical Synthesis of Boc and Fmoc Protected 4-Fluoro and 4-Difluoroprolines from Trans-4-Hydroxyproline”; Tetrahedron Letters, 39, 1998, pp. 1169-1172.
Augustyns, K.J.L.; “Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl petidase IV”; European Journal of Medicinal Chemistry; vol. 32; No. 4; 1997; pp. 301-309; XP004086653.
Database Crossfire Beilstein ′Online!; Beilstein Institut zur Forderung der Chemishen Wissenschaften, Frankfurt am Main, DE; Beilstein Registry No. 6688440 & J. Med. Chem., vol. 36, No. 23, 1993, pp. 3707-3720; XP002242778.
Database Crossfire Beilstein ′Online!; Beilstein Institut zur Forderung der Chemishen Wissenschaften, Frankfurt am Main, DE; Beilstein Registry No. 4298035 & J. Med. Chem., vol. 34, No. 2, 1991, pp. 656-663; XP002242779.
Hughes, et al, NVP-DPP728 (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV; Biochemistry, vol. 38, 1999, pp. 11597-11603.
Aranyi Peter
Balazs Laszlo
Bata Imre
Batori Sandor
Boronkay Eva
Anderson Rebecca
Barker Michael P.
Kurys Barbara E.
Sanofi-Aventis
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3966833